Oncology Institute Stock Forward View - Triple Exponential Smoothing
| TOI Stock | USD 2.73 0.05 1.87% |
Oncology Stock outlook is based on your current time horizon. We suggest always using this module together with an analysis of Oncology Institute's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 3rd of February 2026, the value of RSI of Oncology Institute's share price is approaching 37. This usually implies that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Oncology Institute, making its price go up or down. Momentum 37
Sell Extended
Oversold | Overbought |
Using Oncology Institute hype-based prediction, you can estimate the value of Oncology Institute from the perspective of Oncology Institute response to recently generated media hype and the effects of current headlines on its competitors.
The Triple Exponential Smoothing forecasted value of Oncology Institute on the next trading day is expected to be 2.65 with a mean absolute deviation of 0.15 and the sum of the absolute errors of 8.94. Oncology Institute after-hype prediction price | USD 2.73 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Oncology Institute to cross-verify your projections. For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.Oncology Institute Additional Predictive Modules
Most predictive techniques to examine Oncology price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Oncology using various technical indicators. When you analyze Oncology charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Oncology Institute Triple Exponential Smoothing Price Forecast For the 4th of February
Given 90 days horizon, the Triple Exponential Smoothing forecasted value of Oncology Institute on the next trading day is expected to be 2.65 with a mean absolute deviation of 0.15, mean absolute percentage error of 0.05, and the sum of the absolute errors of 8.94.Please note that although there have been many attempts to predict Oncology Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Oncology Institute's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Oncology Institute Stock Forecast Pattern
| Backtest Oncology Institute | Oncology Institute Price Prediction | Research Analysis |
Oncology Institute Forecasted Value
In the context of forecasting Oncology Institute's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Oncology Institute's downside and upside margins for the forecasting period are 0.03 and 8.70, respectively. We have considered Oncology Institute's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Oncology Institute stock data series using in forecasting. Note that when a statistical model is used to represent Oncology Institute stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | -0.0254 |
| MAD | Mean absolute deviation | 0.1515 |
| MAPE | Mean absolute percentage error | 0.0435 |
| SAE | Sum of the absolute errors | 8.9402 |
Predictive Modules for Oncology Institute
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Oncology Institute. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Oncology Institute After-Hype Price Density Analysis
As far as predicting the price of Oncology Institute at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Oncology Institute or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Oncology Institute, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Oncology Institute Estimiated After-Hype Price Volatility
In the context of predicting Oncology Institute's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Oncology Institute's historical news coverage. Oncology Institute's after-hype downside and upside margins for the prediction period are 0.14 and 8.78, respectively. We have considered Oncology Institute's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Oncology Institute is very risky at this time. Analysis and calculation of next after-hype price of Oncology Institute is based on 3 months time horizon.
Oncology Institute Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Oncology Institute is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Oncology Institute backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Oncology Institute, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.49 | 6.05 | 0.00 | 0.04 | 0 Events / Month | 3 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
2.73 | 2.73 | 0.00 |
|
Oncology Institute Hype Timeline
On the 3rd of February Oncology Institute is traded for 2.73. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.04. Oncology is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is at this time at -0.49%. %. The volatility of related hype on Oncology Institute is about 8287.67%, with the expected price after the next announcement by competition of 2.69. About 43.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.76. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Oncology Institute has Price/Earnings (P/E) ratio of 190.67. The entity recorded a loss per share of 0.67. The firm had not issued any dividends in recent years. Considering the 90-day investment horizon the next estimated press release will be within a week. Check out Historical Fundamental Analysis of Oncology Institute to cross-verify your projections. For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.Oncology Institute Related Hype Analysis
Having access to credible news sources related to Oncology Institute's direct competition is more important than ever and may enhance your ability to predict Oncology Institute's future price movements. Getting to know how Oncology Institute's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Oncology Institute may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| EHAB | Enhabit | (0.12) | 10 per month | 1.72 | 0.13 | 4.81 | (3.26) | 11.79 | |
| AUNA | Auna SA | 0.00 | 0 per month | 0.00 | (0.08) | 4.65 | (4.06) | 23.30 | |
| SNDA | Sonida Senior Living | (0.12) | 3 per month | 0.94 | 0.08 | 3.04 | (1.70) | 8.06 | |
| CCRN | Cross Country Healthcare | 0.00 | 0 per month | 0.00 | (0.13) | 5.51 | (6.07) | 24.90 | |
| EOLS | Evolus Inc | 0.00 | 0 per month | 0.00 | (0.17) | 4.43 | (5.29) | 19.71 | |
| TMCI | Treace Medical Concepts | (0.09) | 8 per month | 0.00 | (0.29) | 5.60 | (5.71) | 31.38 | |
| KIDS | Orthopediatrics Corp | 0.00 | 0 per month | 2.18 | 0.01 | 3.72 | (2.97) | 16.89 | |
| CBLL | CeriBell | 0.00 | 0 per month | 1.84 | 0.28 | 6.39 | (2.87) | 18.00 | |
| AUTL | Autolus Therapeutics | (0.33) | 16 per month | 4.90 | 0.01 | 10.45 | (6.29) | 30.76 | |
| AGL | agilon health | (0.07) | 8 per month | 0.00 | (0.01) | 10.00 | (8.43) | 30.19 |
Other Forecasting Options for Oncology Institute
For every potential investor in Oncology, whether a beginner or expert, Oncology Institute's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Oncology Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Oncology. Basic forecasting techniques help filter out the noise by identifying Oncology Institute's price trends.Oncology Institute Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Oncology Institute stock to make a market-neutral strategy. Peer analysis of Oncology Institute could also be used in its relative valuation, which is a method of valuing Oncology Institute by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Oncology Institute Market Strength Events
Market strength indicators help investors to evaluate how Oncology Institute stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oncology Institute shares will generate the highest return on investment. By undertsting and applying Oncology Institute stock market strength indicators, traders can identify Oncology Institute entry and exit signals to maximize returns.
Oncology Institute Risk Indicators
The analysis of Oncology Institute's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Oncology Institute's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting oncology stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.2 | |||
| Standard Deviation | 6.05 | |||
| Variance | 36.61 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Oncology Institute
The number of cover stories for Oncology Institute depends on current market conditions and Oncology Institute's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Oncology Institute is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Oncology Institute's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Oncology Institute Short Properties
Oncology Institute's future price predictability will typically decrease when Oncology Institute's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Oncology Institute often depends not only on the future outlook of the potential Oncology Institute's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Oncology Institute's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 75 M | |
| Cash And Short Term Investments | 49.7 M |
Check out Historical Fundamental Analysis of Oncology Institute to cross-verify your projections. For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is there potential for Stock market expansion? Will Oncology introduce new products? Factors like these will boost the valuation of Oncology Institute. If investors know Oncology will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Oncology Institute listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Investors evaluate Oncology Institute using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Oncology Institute's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Oncology Institute's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Oncology Institute's value and its price as these two are different measures arrived at by different means. Investors typically determine if Oncology Institute is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Oncology Institute's market price signifies the transaction level at which participants voluntarily complete trades.